We tested associations between risk factors and bone mineral density in airways disease subjects, and developed a clinical screening tool to identify people who could benefit from bone mineral density testing. Subjects were recruited through hospital outpatients and pharmacies (Newcastle, n = 172). With survey refinement, we then tested a revised tool in a second sample (Adelaide, n = 317). Study factors included oral/inhaled corticosteroid use, asthma severity, respiratory admissions, physical activity, percent predicted forced expiratory volume in one second (FEVI), body mass index, and smoking history. Outcomes were bone mineral density of lumbar vertebra (L2-4) and total (or neck of) femur. Analysis was logistic regression with generation of a simple screening algorithm based upon coefficients. Scoring algorithm risk factors for T-score of <-2.0: age > 68 = 10 points, bone mineral density <20 = 25, weight <60 kg = 20, 60-69 kg = 10, > 80 cigarette pack years = 15, low-level leisure activity = 5, area under receiver operator curve 0.83. For a cut-off score of 10, sensitivity was 91.2%, specificity 53.9%, positive and negative predictive values 52.3 and 91.7%, and 67.2% were correctly classified. In conclusions, our model has acceptable sensitivity, although limited specificity. Use of this tool may reduce unnecessary referrals for bone mineral density measurement.
Introduction
Osteoporotic fractures have substantial public health significance, with high economic costs, high 12-month post hip fracture mortality, and loss of independence.1'2 According to a systematic review of studies of bone densities and fractures, subjects with asthma and chronic obstructive airways disease have a high risk of osteoporosis.3 Chronic lung disease is common, with a population prevalence of 1 1% in persons aged over 65 years. 4 Bone mineral density reductions of up to 29% compared to predicted norms have been shown to occur in such subjects,5 with the greatest reductions demonstrated in subjects with severe chronic obstructive airways disease, and with greatest use of oral corticosteroids.3 Such reductions have important fracture implications, as a bone mineral density reduction of the order of one standard deviation (approximately 10%) is associated with a 2.6-fold increase in the risk of hip fracture. 6 Although corticosteroid use is an acknowledged risk factor for osteoporosis, no guidelines are available specifically for patients with chronic obstructive airways disease, to assist in determining who should undergo osteoporosis screening.
Relationships between asthma, reductions in physical activity and, in turn, reduced bone mineral density have also been described.7-9 Other risk factors include poor lung function,'0 smoking,'1 and reduced dietary calcium due to 'milk makes mucus' beliefs. '2 In postmenopausal women, screening tools have been evaluated to determine who should undergo dual emission X-ray absorptiometryl3 for bone mineral density measurement,14 with reported specificity ranging from 29 to 40% when sensitivity is set at approximately 90%, allowing identification of a group of women who do not need dual emission X-ray absorptiometry screening.
Our aim was to develop a clinically applicable risk factor screening tool for use in patients who suffer chronic lung disease, to identify those who may benefit from bone mineral density testing. As with reports of similar screening tool evaluations,13'14 we then aimed to further evaluate the tool in an entirely different sample of subjects.
after the age of 40 years. One point was allocated for inhaled corticosteroid > 1.5 mg daily for > 2 years, FEVy <75% predicted, smoker for >40 pack years, able to walk between 100 and 300 m unaided, and body mass index of < 18 kg/M2. Subjects were contacted by letter and/or telephone, and relevant institutional ethics committees' approvals were obtained in both states.
Exclusion criteria Methods
First sampling frame Newcastle, New South Wales Subjects with asthma and chronic obstructive airways disease, aged between 20 and 71 years, were recruited from: * a major regional chest clinic database at the Royal Newcastle Hospital, and * 46 community pharmacies, in association with the purchase of asthma medication, according to previously reported methodology.15
Second sampling frame Adelaide, South Australia Subjects with asthma and chronic obstructive airways disease, aged between 45 and 80 years, were recruited from three metropolitan teaching hospitals, private practices, and through media publicity. Bone mineral density findings were only slightly below predicted in the Newcastle sample (despite findings of published reports of greater reduction3), therefore a decision was made to target older subjects in Adelaide. Additionally, we targeted a higher morbidity patient population in Adelaide by recruiting inpatients who were identified on the basis of ICD-9 or ICD-10 discharge codes for asthma, chronic bronchitis, emphysema, chronic obstructive airways disease or respiratory failure, in addition to clinic patients. We also administered a brief prescreening checklist questionnaire, supplemented by relevant information through audit of medical records. This checklist was based upon the Newcastle findings as well as the available literature, and was designed to have a low threshold for inclusion. Subjects were required to achieve a score of at least five for study eligibility. Two points were allocated for: >2 prednisolone courses in the last two years, forced expiratory volume in one second (FEVy) < 50% predicted, any respiratory admission in the last five years, unable to walk > 100 m unaided, female aged > 50 years, and fracture Chronic Respiratory Disease In both samples, subjects were excluded if they had bilateral hip replacements, restricted mobility from nonrespiratory disorder (including neurological and musculoskeletal diseases), carcinoma, and cirrhotic liver disease. The Adelaide sample constituted the initial phase of a randomized controlled trial involving alendronate; therefore those patients for whom alendronate was contraindicated were excluded from the study (including alcohol dependence).
Outcome factors
Bone mineral density was measured at the neck of the femur, and lumbar spine (L2-4) using a Lunar DPXP,US dual emission X-ray absorptiometer,16 and expressed as Z-scores (standard deviation above or below the mean compared to matched age and gender) and T-scores (compared to young adult mean for their gender).
Consistent with previously published reports, 14 to identify those at risk of osteoporosis, the principal outcome was a T-score of <-2.0. We also included total femur T-scores in the Adelaide sample.
Study factors
Newcastle sample Total lifetime dose of oral and inhaled corticosteroids was estimated based upon a combination of 1) telephone interview prior to study visit, and 2) inspection of casenotes, prescriptions, and medications brought to the study visit.
Percent predicted FEVy was categorized into severe (<40% of predicted FEVy), moderate (40-59%) and mild (60-79%) according to the British Thoracic Society.17 Asthma severity was classified according to previously reported items7 including age of onset of asthma, duration of asthma, number of days off annually (from school per year from age 10 to 16 years and also off work in the last five years) and lifetime number ofrespiratory admissions. Physical activity was based upon the questionnaire of Baecke et al.,1 with modifications to relate to weight-bearing activity in the last five years. [19] [20] [21] Osteoporosis screening and airways disease BJ Smith et al. 7 Other study factors included total cigarette consumption, menopausal status, daily intake of beer, wine, and dietary calcium in the last five years. 22 Soy-based drinks, rice, pasta, oranges and mandarins were included as some asthmatics may avoid dairy foods, and seek 2~~~~~2 alternative sources of calcium.3 A body mass index <20 kg/M2 was a marker of being underweight.
Adelaide sample
Interviewers noted that Newcastle subjects had found recall of past prescriptions, activity levels, and dietary calcium to be onerous. Also, analysis of the Newcastle data demonstrated a lack of relationship between many of the original broad set of potential risk factors including dietary calcium and bone mineral density. The revised and simplified questionnaire therefore comprised a medication history, which included number of courses of oral corticosteroids in last two years, current use of daily oral corticosteroids, current use of inhaled corticosteroids (none, < 1000 ,ug/day, or > 1000 ,ug/day), theophylline, and other medications (such as current use of thiazide or other diuretics, warfarin, hormone replacement therapy, thyroxine, and anticonvulsants). Respiratory specific risk factors included ever smoked, pack years of cigarette consumption, distance that could be walked before ceasing due to dyspnoea (<100m, 100-300m, >300m), number of respiratory admissions in last five years (categorized as none, 1-2, 3-5, more than 5) and the leisure component only of the Baecke activity questionnaire.18 General risk factors included age, gender, menopausal status and age at menopause, body mass index, maternal fractures, and fractures since age 40 at hip, rib and spine.
Statistical analysis
Multiple logistic regression, using forward selection (entry criterion a = 0.10), was used to identify factors best associated with T-scores <-2 for either spine or total femur. Goodness-of-fit and prognostic value were assessed by Hosmer-Lemeshow chi-squared and area under the receiver operator curve. A simple screening algorithm scoring tool was then generated from the coefficients of the logistic regression (log odds ratio), weighted by the sum of all coefficients, multiplied by 100 and rounded to the nearest five, with sensitivity set at 90% for the T <-2 model. Likelihood ratios were calculated to express the odds that a given level of a diagnostic test result would be expected in a person with T <-2. Likelihood ratios > 1 indicate increased risk of osteoporosis and likelihood ratios < 1 indicate evidence against T <-2. Likelihood ratios may be applied to populations with different underlying prevalence of osteoporosis, with post-test odds ofT <-2 estimated by multiplying the pretest odds ofT < -2 by all the relevant likelihood ratios. For this application, adjusted likelihood ratios are given to enable multiplication of each likelihood ratio controlled for the other factors in the final model, and were estimated using the generalized linear model for presence and absence of each factor with binomial family, log link and Newton-Raphson (maximum likelihood) optimization. All analyses were performed using Stata Version 6.0.24 pharmacies and 111 subjects via chest clinic. Table  2 (a) shows the bone mineral density findings by site in the screened sample. Both spine and neck of femur T-scores of <-2 were present in 13 people, and 41 (24%) had T <-2 at either or both sites. Table 3 summarizes the logistic regression analysis of the relationship between potential predictors and low bone mineral density (T-score <-2) at either hip or spine, and provides a simple scoring algorithm using a total score of 25 as the cut-off for performing bone mineral density testing. Figure 1 demonstrates a receiver operator curve summary of the relationship between the algorithm scoring tool, according to points allocated for each risk factor in Table 3 , and the sensitivity and specificity for predicting low bone mineral density. To successfully identify those subjects with T <-2 at either hip or spine (n = 41), with a setting of the threshold score at 25, we had a sensitivity of 95.1%, specificity of 58.0%, positive predictive value of 41.5%, negative predictive value of 97.4%, and 66.9% of subjects were correctly classified.
Results

Newcastle sample
Adelaide sample
A revised screening questionnaire was administered to the Adelaide sample (n = 317) with participant characteristics summarized in Table l(b). Volunteers were recruited from hospital admissions (171), public respiratory clinics (71), regional general practitioners (29), private respiratory clinics (23), and via media or other sources (23) . This sample was older and with more severe chronic obstructive airways disease than the Newcastle sample. Of 317 subjects, 299 (94%) had spine bone mineral density measurements. The remainder were unavailable Chronic Respiratory Disease due to technical limitations associated with extreme girth, or suspected vertebral crush fractures impeding interpretation. Femur data were available in 315 (one withdrawal due to hospital noise, one post-polio limitations). and spine were r = 0.58 and 0.69 for T-scores and Z-scores, respectively. Both spine and total femur T-scores of <-2 were present in 53 (17.8%) of 297 people, and T-score was <-2.0 in 113 subjects (35.7%) at either site. Table 4 summarizes the results of regression analysis forward selection of risk factors for T <-2 at either spine or total femur. The 'scoring algorithm points' column in Table 4 provides the final screening points scoring tool. A total score of at least 10 points provides an indication to proceed with bone mineral density testing. Table 4 Adelaide results of the forward selection (a: Table 5 demonstrates the likelihood ratios and scoring system based upon the logistic regression findings. Figure 2 is the receiver operator curve for the T <-2 at either site using that scoring algorithm, with the actual scores overlayed onto the graph, illustrating the sensitivity and specificity of having that score or higher. To identify those subjects with T < -2 at either hip or spine (n = 113), with a setting of the threshold score at 10, we demonstrated a sensitivity of 91.2%, specificity of 53.9%, positive predictive value of 52.3%, negative predictive value of 91.7%, and 67.2% of subjects were correctly classified. A score of less than 10 was present in 120 of 317 people (38%) and is unlikely to yield a T-score <-2 as the negative predictive value is 91.7%. Figure 3 demonstrates the distribution of the scores for the Adelaide sample in relation to a T-score of <-2.0.
Discussion
We have tested potential predictors of bone mineral density, using screening questionnaires, in two samples of subjects who have chronic lung disease. Newcastle subjects had difficulty with our original questionnaire. Therefore, rather than validating the same questionnaire in the second sample, we chose to improve the 0.10) logistic regression for T <-2.0: at either spine (L2 -4) or total femur" OR (95% CI) ither spine bOdds increases by factor of 2.58 for each category decrease in weight. Also considered but not selected in the model were booster and maintenance prednisolone, current theophylline for males, thyroxine, any respiratory admissions in the last five years, % predicted FEVI, exercise tolerance, frusemide, inhaled corticosteroids, fracture of rib, spine or hip, and ever smoked.
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10 Table 5 Adelaide sensitivity, specificity, and probability of T < -2.0 for each total algorithm score ease-of-use and utility ofthe questionnaire for testing in the second sample. Both our final predictive models for Newcastle and Adelaide retained only six items to help predict a T-score of < -2 by use of a simple point scoring system. A score of 10 can be readily obtained by any one of five out of six of these items in our final Adelaide model, and thereby facilitate a quick decision for the patient to undergo bone mineral density testing or not. Our final Adelaide model could be filled out at least in part by subjects themselves, missed less than one in 10 subjects with a T-score of < -2 due to good negative predictive value, and correctly classified two in three subjects. However, our low specificity would require a large number of normal bone densities to be performed, and area under the receiver operator curve was modest.
Our final algorithm provides an alternative to the current practices of ad hoc screening, if screening occurs at all in this patient group.3 In order to make an appropriate decision regarding the overall worth of screening programs such as these, cost-effectiveness evaluation is necessary (including estimates of cost saving through averted fractures). Greater awareness of the possibility of reduced bone mineral density in this sample, based upon an algorithm, may encourage clinicians and patients alike to give greater consideration to back titration of oral and inhaled corticosteroids where clinically appropriate, and to adopt lifestyle changes such as increasing the amount of regular physical activity.
Limitations to our screening tool development included that the second study in Adelaide was not strictly a validation exercise, as we revised the Newcastle questionnaire to make it more user-friendly. Our aim was initially to develop an algorithm in one population (Newcastle), and validate in a second population. However, many Newcastle study participants were elderly and frail, responding to the questionnaire in the population was found at times to be onerous, and therefore probably unsustainable as a screening tool. The Newcastle findings are presented nevertheless as this had been the a priori intention. Validation of our final algorithm therefore now needs to be performed, preferably with comparison of long-term outcomes against a no-tool group. The protective effect of theophylline in females may relate to unusual characteristics of a small number of subjects so may be a spurious finding. It is inconsistent with previously reviewed bone effects of this class of drugs,3 and should be included as part of a clinical practice screening tool with caution. However, other predictive factors in our final algorithm were consistent with the available evidence. Heavy alcohol consumption is associated with bone mineral density reduction, but not when taken in moderation.25 Due to alcohol dependence being an exclusion criteria in the Adelaide study, we did not further explore the association found in our Newcastle subjects. A history of heavy cigarette consumption and limited physical activity are often seen in chronic lung disease. Our final algorithm, however, does not otherwise differ from general population questionnaires.
Screening algorithms have been proposed and evaluated in other at-risk groups such as postmenopausal women,13"14 demonstrating specificities ranging from 29 to 45% when sensitivity is set at 90% or more, with area under the receiver operator curve up to 0.79. These studies included the use of simple algorithm tools such as the 'SCORE'.13 Our negative predictive value of 91.7% compares favourably with other literature estimates at T <-2 of 75%.26 Our positive predictive value of 52.3% at T < -2 is within the range of previously published osteoporosis screening reports. Pre-dual emission X-ray absorptiometry screening tools such as 'SCORE' have been estimated to reduce the costs of screening programmes by approximately one-fifth by identifying women likely to have normal bone mineral density who do not require dual emission X-ray absorptiometry.27 Given that the utility of our screening questionnaire was at least similar to these previous screening tool utility reports in other at-risk groups, savings may occur when prescreening people with chronic lung disease with our final algorithm before proceeding to dual emission X-ray absorptiometry. However, the best choice of T-score will be largely dependent on results of future screening and treatment programme cost-effectiveness evaluations, which are yet to be performed.
Neither our Newcastle or Adelaide samples had the extent of bone mineral density reduction demonstrated in many previous reports of apparently similar subjects.3 This may relate to publication bias of previous reports, or to our adherence to a structured sampling frame, whereas most other previous reports provided limited sampling detail, perhaps suggesting convenience sampling of self-selected or particularly high-risk subjects.
The algorithm appears to overemphasize the role of lung disease, compared to body mass index. However the model is based upon capabilities of factors to predict low bone mineral denisty, rather than apportioning causations to bone mineral density loss. One study factor may have predictive value on behalfof a number of other potential predictive factors due to interfactor correlations, leading to a shortened final set of predictive factors through the regression analysis.
Greater specificity for a screening algorithm might be attained through the development of new markers of bone health, as could be attained through finger prick assays. Rapid assays of markers of bone metabolism, when within a normal range, may reduce the number of bone mineral density tests being performed on normal subjects. This is the first reported evaluation of a screening process for people with asthma and chronic obstructive airways disease. We have proposed a simple algorithm tool (Table 4) , with associated probabilities of bone mineral density reduction to facilitate patient selection for referral for bone mineral density testing. Currently, in the absence of any reported guidelines or recommendations for patient selection, there is no standard practice for referrals for bone mineral density. This algorithm tool may provide a helpful step toward better practice.
